Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood

Human adaptive-like “memory” CD56dimCD16⁺ natural killer (NK) cells in peripheral blood from cytomegalovirus-seropositive individuals have been extensively investigated in recent years and are currently explored as a treatment strategy for hematological cancers. However, treatment of solid tumors re...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 11; pp. 1 - 12
Main Authors: Brownlie, Demi, Scharenberg, Marlena, Mold, Jeff E., Hård, Joanna, Kekäläinen, Eliisa, Buggert, Marcus, Nguyen, Son, Wilson, Jennifer N., Al-Ameri, Mamdoh, Ljunggren, Hans-Gustaf, Marquardt, Nicole, Michaëlsson, Jakob
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 16-03-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Human adaptive-like “memory” CD56dimCD16⁺ natural killer (NK) cells in peripheral blood from cytomegalovirus-seropositive individuals have been extensively investigated in recent years and are currently explored as a treatment strategy for hematological cancers. However, treatment of solid tumors remains limited due to insufficient NK cell tumor infiltration, and it is unknown whether large expansions of adaptive-like NK cells that are equipped for tissue residency and tumor homing exist in peripheral tissues. Here, we show that human lung and blood contains adaptivelike CD56brightCD16⁻ NK cells with hallmarks of tissue residency, including expression of CD49a. Expansions of adaptive-like lung tissue-resident NK (trNK) cells were found to be present independently of adaptive-like CD56dimCD16⁺ NK cells and to be hyperresponsive toward target cells. Together, our data demonstrate that phenotypically, functionally, and developmentally distinct subsets of adaptive-like NK cells exist in human lung and blood. Given their tissue-related character and hyperresponsiveness, human lung adaptive-like trNK cells might represent a suitable alternative for therapies targeting solid tumors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
2N.M. and J.M. contributed equally to this work.
Author contributions: N.M. and J.M. designed research; D.B., M.S., J.E.M., J.H., J.N.W., N.M., and J.M. performed research; M.A.-A. contributed new reagents/analytic tools; D.B., M.S., J.E.M., J.H., E.K., M.B., S.N., J.N.W., N.M., and J.M. analyzed data; H.-G.L., N.M., and J.M. provided funding; and H.-G.L., N.M., and J.M. wrote the paper.
1D.B. and M.S. contributed equally to this work.
Edited by Marco Colonna, Washington University in St. Louis School of Medicine, St. Louis, MO, and approved January 27, 2021 (received for review August 18, 2020)
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.2016580118